Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
US6054441A · kind A · utility
5Cited by
11References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1995 |
| Grant date | Apr 25, 2000 |
| Priority date | — |
| Expiry date | Jun 5, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/167
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to certain oxypurine nucleosides, congeners of such oxypurine nucleosides, and acyl derivatives thereof, and compositions which contain at least one of these compounds. The invention also relates to methods of treating or preventing hematopoietic disorders and modifying hematopoiesis, and treating or preventing inflammatory diseases and bacterial infections by administering a compound or composition of the present invention to an animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.